Association of fecal short-chain fatty acids with clinical severity and gut microbiota in essential tremor and its difference from Parkinson's diseaseOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study measured fecal short-chain fatty acids in essential tremor and asked whether they could serve as diagnostic markers. Researchers compared tremor patients to healthy controls and to newly diagnosed Parkinson's disease, linking the acids to gut bacteria and symptom severity. Fecal levels of propionic, acetic, butyric, isovaleric and isobutyric acid were measured by gas and liquid chromatography mass spectrometry. Stool 16S rRNA sequencing profiled the gut microbiota. Constipation, autonomic function and tremor severity were rated with validated clinical scales. The design was cross-sectional, so it cannot establish cause.
Who was studied?
The cohort was 109 adults from a movement disorders clinic in Shanghai, China, enrolled between 2019 and 2022. It included 37 people with essential tremor, 37 with newly diagnosed drug-naive Parkinson's disease, and 35 healthy controls. The three groups were matched for age, sex and body mass index, with similar smoking, alcohol, coffee and tea habits. People with chronic gastrointestinal disease, recent antibiotic or probiotic use, or vegetarian diets were excluded. The tremor group had longer disease duration than the Parkinson's group.
What were the most important findings?
Essential tremor patients had lower fecal propionic, butyric and isobutyric acid than healthy controls. Combining propionic, butyric and isobutyric acid separated tremor from controls with an AUC of 0.751 (95% CI 0.634 to 0.867), at 74.3% sensitivity and 72.9% specificity. Tremor patients also had lower isovaleric and isobutyric acid than Parkinson's patients. That pair distinguished the two diseases with an AUC of 0.743. Fecal propionic acid fell as constipation and autonomic dysfunction worsened. Lower isobutyric and isovaleric acid tracked with greater tremor severity. Reduced acids matched lower abundance of the fiber-fermenting genera Faecalibacterium and Catenibacterium in tremor patients.
What are the greatest implications of this study?
The results suggest fecal short-chain fatty acids may become supportive markers for diagnosing essential tremor and separating it from Parkinson's disease. Isobutyric acid changes looked especially specific to tremor, since they differed from both Parkinson's and control groups. Because the acids fell alongside butyrate-producing bacteria, the findings point to the gut-brain axis in tremor biology. The study was cross-sectional and modest in size, so causation is unproven. The authors call for larger, independent and longitudinal cohorts before clinical use.